Latest Stock Market News

Regional banks make a hefty chunk of their revenues from net interest margins, boosting their appeal as investors increasingly expect the Fed to hike interest rates more aggressively this year to control inflation. The central bank meets next week and is expected to raise interest rates as soon as March.

Rate this item

(1 Vote)

You might see some degree of bounce shaping up on the indices but that four days of selling which you have seen on the trot for the indices indicate that there could be more pain ahead in terms of individual stocks.

Drugmaker Biocon is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit growth in the next several quarters, primarily from the US market.

The coming week is expected to see the levels of 17,750 and 17,800 acting as resistance points. The supports are likely to come in at 17,500 and 17,350 levels. The trading range is likely to get a bit narrower as compared to the previous week.

The auction route will be undertaken mainly to get improved offers so as to prevent the company from going into liquidation since the offers from all four bidders are below the liquidation value, they said. The Reliance Industries-Assets Care & Reconstruction Enterprise (ACRE) team, a Welspun entity, Himatsingka Ventures and GHCL have submitted resolution plans last month.

Rate this item

(1 Vote)

In the issue, 50% will be reserved for qualified institutional buyers (QIBs). Non-institutional buyers will have 15% of the share issue. The retail portion will get up to 35% of the offer.

AGS Transact IPO subscribed 7.79x on final day

Updated at : 2022-01-22 12:20:03

Rate this item

(1 Vote)

The issue - the first IPO in 2022 - received applications for 22.35 crore shares against the 2.87 crore shares on offer.

SBI Life Q3 Results: Standalone net profit rises 56%

Updated at : 2022-01-22 12:20:03

Rate this item

(1 Vote)

​​Protection new business premium increased by 26 per cent from ₹1,620 crore in this fiscal so far to ₹2,040 crore.

Kotak Institutional Equities is expecting the lender to report Rs 217.80 crore in losses for the quarter compared with a profit of Rs 225.50 crore in the September quarter and Rs 150.70 crore in the December quarter last year.

Rate this item

(1 Vote)

The O2C business saw a marked improvement driven by the improving spread of diesel and ATF, expanding the realisation of refineries. The Singapore GRM - a gauge of regional refining margins - rose to $6.1 per barrel in the December quarter, a two-year high.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.